DC expressing transgene Foxp3 are regulatory APC

European Journal of Immunology

Volumn 40, Issue 2, 2010, Pages 480-493

  Lipscomb, Michael W ^a   Taylor, Jennifer L ^a   Goldbach, Cristina J ^a   Watkins, Simon C ^a   Wesa, Amy K ^a   Storkus, Walter J ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Allogeneic; DC; Foxp3; Staphylococcus enterotoxin B; Treg

Indexed keywords

TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ANTIGEN PRESENTING CELL; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNITY; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH2 CELL; TRANSGENICS;

ANTIBODIES, NEUTRALIZING; ANTIGEN-PRESENTING CELLS; BICYCLO COMPOUNDS, HETEROCYCLIC; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICROSCOPY, FLUORESCENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 75149125252     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939667     Document Type: Article

References (40)

1. Miller, S. D., Turley, D. M. and Podojil, J. R., Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat. Rev. Immunol. 2007. 7: 665-677.
2. Felix, N. J. and Allen, P. M., Specificity of T cell alloreactivity. Nat. Rev. Immunol. 2007. 7: 942-953.
3. Kapsenberg, M. L., Dendritic-cell control of pathogen-driven T cell polarization. Nat. Rev. Immunol. 2003. 3: 984-993.
4. Rossi, M. and Young, J. W., Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J. Immunol. 2005. 175: 1373-1381.
5. Heath, W. R., Belz, G. T., Behrens, G. M. N., Smith, C. M., Forehan, S. P., Parish, I. A., Davey, G. M. et al., Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 2004. 199: 9-26.
6. Sato, K., Yamashita, N., Yamashita, N., Baba, M. and Matsuyama, T., Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 2003. 18: 367-379.
7. Morelli, A. E. and Thomson, A. W., Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 2007. 7: 610-621.
8. Sato, K., Yamashita, N., Baba, M. and Matsuyama, T., Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 2003. 101: 3581-3589.
9. Hannenhalli, S. and Kaestner, K. H., The evolution of fox genes and their role in development and disease. Nat. Rev. Genet. 2009. 10: 233-240.
10. Myatt, S. S. and Lam, E. W., The emerging roles of forkhead box (Fox) proteins in cancer. Nat. Rev. Cancer 2007. 7: 847-859.
11. Wan, Y. Y. and Flavell, R. A., Regulatory T cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007. 445: 766-770.
12. Zheng, Y. and Rudensky, A. Y., Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 2007. 8: 457-462.
13. Zheng, Y., Josefowicz, S. Z., Kas, A., Chu, T., Gavin, M. A. and Rudensky, A. Y., Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007. 445: 936-940.
14. Hinz, S., Pagerols-Raluy, L., Oberg, H., Ammerpohl, O., Grüssel, S., Sipos, B., Grützmann, R. et al., Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res 2007. 67: 8344-8350.
15. Fallarino, F., Bianchi, R., Orabona, C., Vacca, C., Belladonna, M. L., Fioretti, M. C., Serreze, D. V. et al., CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice. J. Exp. Med. 2004. 200: 1051-1062.
16. Dejean, A. S., Beisner, D. R., Chen, I. L., Kerdiles, Y. M., Babour, A., Arden, K. C., Castrillon, D. H. et al., Transcription factor foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells. Nat. Immunol. 2009. 10: 504-513.
17. + T cells. Curr. Opin. Immunol. 2003. 15: 336-342.
18. Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G. and Levings, M. K., Activation-induced Foxp3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 2007. 19: 345-354.
19. Pillai, V., Ortega, S. B., Wang, C. K. and Karandikar, N. J., Transient regulatory T-cells: a state attained by all activated human T cells. Clin. Immunol. 2007. 123: 18-29.
20. Munn, D. H. and Mellor, A. L., Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 2007. 117: 1147-1154.
21. Wrzesinski, S. H., Wan, Y. Y. and Flavell, R. A., Transforming growth factor-β and the immune response: implications for anticancer therapy. Clin. Cancer Res. 2007. 13: 5262-5270.
22. Danke, N. A. and Kwok, W. W., HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination. J. Immunol. 2003. 171: 3163-3169.
23. Asirvatham, A. J., Magner, W. J. and Tomasi, T. B., miRNA regulation of cytokine genes. Cytokine 2009. 45: 58-69.
24. Smith, A. M., Rahman, F. Z, Hayee, B., Graham, S. J., Marks, D. J., Sewell, G. W., Palmer, C. D. et al., Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J. Exp. Med. 2009. 206: 1883-1897.
25. Couper, K. N., Blount, D. G. and Riley, E. M., IL-10: the master regulator of immunity to infection. J. Immunol. 2008. 180: 5771-5777.
26. Ledru, E., Lecoeur, H., Garcia, S., Debord, T. and Gougeon, M. L., Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J. Immunol. 1998. 160: 3194-3206.
27. Roozendaal, R., Vellenga, E., de Jong, M. A., Traanberg, K. F., Postma, D. S, de Monchy, J. G. and Kauffman, H. F., Resistance of activated human Th2 cells to NO-induced apoptosis is mediated by gamma- glutamyltranspeptidase. Int. Immunol. 2001. 13: 519-528.
28. Fallarino, F., Grohmann, U., Vacca, C., Orabona, C., Spreca, A., Fioretti, M. C. and Puccetti, P., T cell apoptosis by kynurenines. Adv. Exp. Med. Biol. 2003. 527: 183-190.
29. Toscano, M. A., Bianco, G. A., Ilarregui, J. M., Croci, D. O., Correale, J., Hernandez, J. D., Zwirner, N. W. et al., Differential glycosylation of Th1, Th2 and Th17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 2007. 8: 825-834.
30. Wan, Y. Y., Leon, R. P., Marks, R., Cham, C. M., Schaack, J., Gajewski, T. F. and DeGregori, J., Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells. Proc. Natl. Acad. Sci. USA 2000. 97: 13784-13789.
31. Watkins, S. C. and Salter, R. D., Functional connectivity between immune cells mediated by tunneling nanotubules. Immunity 2005. 23: 309-318.
32. + T suppressor cells are back to the game: are they players in autoimmunity? Autoimmun. Rev. 2002. 1: 279-283.
33. Ndhlovu, L. C., Takeda, I., Sugamura, K. and Ishii, N., Expanding role of T-cell costimulators in regulatory T-cell function: recent advances in accessory molecules expressed on both regulatory and nonregulatory T cells. Crit. Rev. Immunol. 2004. 24: 251-266.
34. + Tregs. J. Clin. Invest. 2005. 115: 3276-3284.
35. Mellor, A. L., Baban, B., Chandler, P., Marshall, B., Jhaver, K., Hansen, A., Koni, P. A. et al., Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 2003. 171: 1652-1655.
36. Sakaguchi, S., Regulatory T cells in the past and for the future. Eur. J. Immunol. 2008. 38: 901-937.
37. Riley, J. L., June, C. H. and Blazar, B. R., Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 2009. 30: 656-665.
38. Ranieri, E., Herr, W., Gambotto, A., Olson, W., Rowe, D., Robbins, P. D., Kierstead, L. S. et al., Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination. J. Virol. 1999. 73: 10416-10425.
39. + T cell responses in vitro. J. Immunother. 2007. 30: 75-82.
40. Kierstead, L. S., Ranieri, E., Olson, W., Brusic, V., Sidney, J., Sette, A., Kasamon, Y. L. et al., gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+ T cells. Br. J. Cancer. 2001. 85: 1738-1745.